Lisa Pruss

Lisa Pruss is a highly experienced regulatory affairs professional currently serving as the VP, Head Regulatory Affairs Strategy for Immunology at Sobi - Swedish Orphan Biovitrum AB since May 2023. Prior to this role, Lisa held significant positions at LEO Pharma as Sr. Director, Global Regulatory Lead for the Innovative Portfolio, and at Bayer as Director, Global Regulatory Strategist. Additionally, Lisa's tenure at Sanofi encompassed various leadership roles in regulatory affairs, including Director for Global Regulatory Affairs and Global Regulatory Team Leader for Oncology. Lisa's experience includes extensive involvement in US regulatory submissions, compliance, and clinical trial support, stemming from a solid foundation in pharmacy with a Pharm.D. degree from St. John's University.